Truist Financial
NVO

Truist Financial’s Novo Nordisk NVO Stock Holding History

Truist Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35M Sell
730,624
-80,448
-10% -$3.46M 0.04% 318
2026
Q1 		$29.8M Buy
811,072
+115,908
+17% +$5.49M 0.04% 328
2025
Q4 		$35.4M Sell
695,164
-85,582
-11% -$4.38M 0.05% 297
2025
Q3 		$43.3M Buy
780,746
+119,098
+18% +$6.97M 0.06% 261
2025
Q2 		$45.7M Buy
661,648
+6,440
+1% +$438K 0.07% 250
2025
Q1 		$45.5M Buy
655,208
+91,974
+16% +$7.6M 0.07% 235
2024
Q4 		$48.4M Sell
563,234
-12,561
-2% -$1.36M 0.08% 230
2024
Q3 		$68.6M Sell
575,795
-36,572
-6% -$4.88M 0.11% 184
2024
Q2 		$87.4M Sell
612,367
-7,321
-1% -$970K 0.13% 156
2024
Q1 		$79.6M Buy
619,688
+22,629
+4% +$2.69M 0.12% 170
2023
Q4 		$61.8M Buy
597,059
+9,450
+2% +$935K 0.1% 199
2023
Q3 		$53.4M Sell
587,609
-17,893
-3% -$1.58M 0.09% 205
2023
Q2 		$49M Sell
605,502
-16,384
-3% -$1.34M 0.08% 222
2023
Q1 		$49.5M Sell
621,886
-93,850
-13% -$6.65M 0.09% 220
2022
Q4 		$48.4M Sell
715,736
-12,562
-2% -$737K 0.09% 217
2022
Q3 		$36.3M Buy
728,298
+5,432
+0.8% +$291K 0.07% 249
2022
Q2 		$40.3M Sell
722,866
-61,404
-8% -$3.41M 0.07% 245
2022
Q1 		$43.5M Buy
784,270
+40,194
+5% +$2.06M 0.07% 260
2021
Q4 		$41.7M Sell
744,076
-3,858
-0.5% -$209K 0.06% 278
2021
Q3 		$35.9M Sell
747,934
-148,184
-17% -$7.16M 0.06% 287
2021
Q2 		$37.5M Sell
896,118
-6,696
-0.7% -$260K 0.06% 283
2021
Q1 		$30.4M Buy
902,814
+52,534
+6% +$1.87M 0.05% 311
2020
Q4 		$29.7M Buy
850,280
+14,696
+2% +$508K 0.06% 295
2020
Q3 		$29M Buy
835,584
+53,352
+7% +$1.78M 0.06% 269
2020
Q2 		$25.6M Sell
782,232
-204,200
-21% -$6.52M 0.06% 295
2020
Q1 		$29.7M Buy
986,432
+84,164
+9% +$2.51M 0.08% 250
2019
Q4 		$26.1M Buy
902,268
+594,364
+193% +$16.5M 0.05% 348
2019
Q3 		$7.96M Buy
307,904
+5,736
+2% +$145K 0.14% 168
2019
Q2 		$7.71M Buy
302,168
+2,568
+0.9% +$63.5K 0.13% 167
2019
Q1 		$7.84M Buy
299,600
+4,394
+1% +$108K 0.14% 159
2018
Q4 		$6.8M Buy
295,206
+7,834
+3% +$174K 0.14% 162
2018
Q3 		$6.77M Buy
287,372
+5,396
+2% +$132K 0.12% 189
2018
Q2 		$6.5M Sell
281,976
-6,654
-2% -$158K 0.12% 192
2018
Q1 		$7.11M Buy
288,630
+16,030
+6% +$421K 0.14% 188
2017
Q4 		$7.32M Buy
272,600
+16,000
+6% +$407K 0.14% 182
2017
Q3 		$6.18M Buy
256,600
+32,404
+14% +$732K 0.12% 211
2017
Q2 		$4.81M Buy
224,196
+6,138
+3% +$124K 0.1% 253
2017
Q1 		$3.74M Buy
218,058
+40,016
+22% +$697K 0.08% 281
2016
Q4 		$3.19M Sell
178,042
-4,624
-3% -$83.8K 0.07% 299
2016
Q3 		$3.8M Buy
182,666
+218
+0.1% +$5.41K 0.08% 274
2016
Q2 		$4.91M Sell
182,448
-21,202
-10% -$581K 0.1% 227
2016
Q1 		$5.52M Sell
203,650
-29,314
-13% -$785K 0.14% 171
2015
Q4 		$6.76M Sell
232,964
-10,638
-4% -$294K 0.18% 154
2015
Q3 		$6.61M Buy
243,602
+37,710
+18% +$1.07M 0.17% 162
2015
Q2 		$5.64M Sell
205,892
-5,294
-3% -$149K 0.15% 168
2015
Q1 		$5.64M Sell
211,186
-8,404
-4% -$194K 0.16% 160
2014
Q4 		$4.65M Sell
219,590
-3,722
-2% -$83.1K 0.14% 178
2014
Q3 		$5.32M Sell
223,312
-8,836
-4% -$203K 0.16% 154
2014
Q2 		$5.36M Buy
232,148
+9,482
+4% +$209K 0.16% 152
2014
Q1 		$5.08M Buy
222,666
+33,726
+18% +$719K 0.16% 158
2013
Q4 		$3.49M Buy
188,940
+7,560
+4% +$132K 0.11% 204
2013
Q3 		$3.07M Buy
181,380
+41,280
+29% +$694K 0.11% 211
2013
Q2 		$2.17M Buy
+140,100
New +$2.33M 0.08% 235

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Truist Financial's NVO Position: Q2 2026 in Review

Truist Financial reduced its Novo Nordisk (NVO) stake by 9.9% in Q2 2026, selling an estimated $3.46M and leaving 730,624 shares worth $35M. The position accounts for 0.04% of the portfolio, ranked #318.

Truist Financial first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $87.4M in Q2 2024. 520 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Truist Financial held 730,624 shares of Novo Nordisk worth $35M as of Q2 2026.
  • Truist Financial sold 80,448 Novo Nordisk shares in Q2 2026, an estimated $3.46M.
  • Novo Nordisk made up 0.04% of Truist Financial's portfolio in Q2 2026, its #318 holding.
  • Truist Financial first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Novo Nordisk position peaked at $87.4M in Q2 2024.
  • 520 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.